On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)-Reference-Cited by-同舟云学术

On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)

Published:2016-12 Issue: Volume:182 Page:89-96
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Blazing Michael A.,Giugliano Robert P.,de Lemos James A.,Cannon Christopher P.,Tonkin Andrew,Ballantyne Christie M.,Lewis Basil S.,Musliner Thomas A.,Tershakovec Andrew M.,Lokhnygina Yuliya,White Jennifer A.,Reist Craig,McCagg Amy,Braunwald Eugene

Funder

Merck

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials;Morrone;Atherosclerosis,2012

2. Simvastatin with or without ezetimibe in familial hypercholesterolemia;Kastelein;N Engl J Med,2008

3. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration;Villines;J Am Coll Cardiol,2010

4. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis;Rossebø;N Engl J Med,2008

5. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes;Cannon;Am Heart J,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary prevention statin therapy in older adults;Current Opinion in Cardiology;2022-11-02

2. Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis;Circulation: Cardiovascular Quality and Outcomes;2022-06

3. Have We Learnt all from IMPROVE-IT? Part II. Subanalyses of the Effects of Ezetimibe Added to Statin Therapy on Selected Clinical and Laboratory Outcomes, Cost-Effectiveness, Guidelines, and Clinical Implications;Current Vascular Pharmacology;2021-09

4. Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease);Current Vascular Pharmacology;2021-09

5. Severe aortic valve stenosis with rapidly progressive atherosclerosis in a young woman with homozygous familial hypercholesterolemia: the possibilities of surgical and therapeutic treatment;Kardiologicheskii vestnik;2021